Skip to main content
Percy Lee, MD, Radiation Oncology, Irvine, CA

PercyPo-YihLeeMD(He/Him)

Radiation Oncology Irvine, CA

Gastrointestinal Cancer, Thoracic Cancer, Urologic Cancer

Professor and Vice Chair of Clinical Research, Medical Director of Orange County and Coastal Radiation Oncology

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    1000 Fivepoint
    Irvine, CA 92618
    Phone+1 888-333-4673

Summary

  • Dr. Lee is Professor and system-wide Vice-Chair for Clinical Research in radiation oncology at City of Hope National Medical Center (Los Angeles County, Orange County, Atlanta, Chicago, and Phoenix). In addition, he serves as the Medical Director
    for Orange County and the Coastal Regions in the Department of Radiation Oncology at City of Hope National Medical Center (City of Hope Orange County, Lennar Foundation Cancer Center in addition to 3 other radiation oncology network sites in the region).
    Previously, he served as Section Chief for Thoracic Radiation Oncology at MD
    Anderson Cancer Center (MDACC) from 2019-2022, and Executive Section Chief for the Department of Radiation Oncology at MDACC from 2021-2022. Dr. Lee started his career at UCLA (2008-2019) where he rose to the rank of Professor and Vice Chair for Education for the Department of Radiation. At UCLA, he served as Chief of Thoracic Radiation Oncology, Residency Training Program Director, and Director of the Stereotactic Body Radiation Therapy Program (SBRT), a program he founded in 2008.

    He is an internationally recognized subject matter expert and thought leader in the clinical applications of SBRT. He has over 220 peer-reviewed publications on the clinical use, evidence for, and application of SBRT in the clinic. Dr. Lee has an international reputation in the treatment of thoracic and GI malignancies. He pioneered
    novel radiosurgery and SBRT technologies such as MRI-guided radiation therapy in the clinic with more than 55 peer-reviewed publications on this subject. He led the clinical implementation of MRI-guided radiation therapy program at UCLA as the 3rd site in the world with this innovation. In addition, he is a clinical trialist who is interested in combining novel radiation therapy approaches with new drugs to achieve improved outcomes in thoracic malignancies. He has served on various leadership roles within national organizations such as ASTRO, RSS, ABR, and ARS.
  • MRIdian offers promising solution to cancer patients

    Four years ago, doctors diagnosed 51-year-old Lori Milla, of San Luis Obispo, with breast cancer that spread to her liver. Her doctors were able to keep the tum

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityChief Residency, Radiation Oncology, 2007 - 2008
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2004 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003, M.D., Magna Cum Laude
  • Johns Hopkins University
    Johns Hopkins UniversityBS, Biomedical Engineering, General and Department Honors, 1994 - 1998
  • Johns Hopkins University
    Johns Hopkins UniversityB.S., Biomedical Engineering, 1994 - 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CA State Medical License
    CA State Medical License 2004 - 2026
  • TX State Medical License
    TX State Medical License 2019 - 2023
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctors 2013 Southern California Rising Stars, 2013
  • Best Doctors in America 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • High Radiotherapy Dose to Ipsilateral Cancer Stem Cell Niche Confers Improved Outcomes in Glioblastoma: A Pooled Analysis  
    Lee, P., Lagerwaard, F., Cloughsy, T., Slotman, B., Wang, P.C., Kupelian, P., Pajonk, F., Selch, M.T., Kang, J., International Journal of Radiation Oncology*Biology*Physics, 7/15/2013
  • 4pi Non-Coplanar SBRT for Centrally Located or Large Tumors  
    Dong, P., Lee, P., Ruan, D., Long, T., Romeijn, E., Low, D., Kupelian, P., Abraham, J., Yang, Y., Sheng, K., International Journal of Radiation Oncology*Biology*Physics, 7/1/2013
  • Assessment of Interfraction Patient Setup for Head-and Neck Cancer Intensity Modulated Radiotherapy Using Multiple CT Based Image Guidance  
    Qi, X.S., Hu, A., Lee, S., Lee, P., Demarco, J., Li, A.X., Steinberg, M., Kupelian, P., Low, D., International Journal of Radiation Oncology*Biology*Physics, 7/1/2013
  • Join now to see all

Press Mentions

  • City of Hope Orange County Celebrates 100th and 101st Patients Treated with County’s Most Advanced Radiation Oncology Technology
    City of Hope Orange County Celebrates 100th and 101st Patients Treated with County’s Most Advanced Radiation Oncology TechnologyNovember 12th, 2024
  • High-Dose Radiotherapy with Chemotherapy Effective in Treating People with Non-Small Cell Lung Cancer
    High-Dose Radiotherapy with Chemotherapy Effective in Treating People with Non-Small Cell Lung CancerJanuary 11th, 2024
  • First Patient Enrolled in Stereotactic MRI-Guided on-Table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer
    First Patient Enrolled in Stereotactic MRI-Guided on-Table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic CancerJanuary 4th, 2019
  • Join now to see all

Professional Memberships

Other Languages

  • Chinese (Mandarin), Taiwanese